Lankenau — Wynnewood, Pennsylvania

Lankenau is a clinical research site located in Wynnewood, Pennsylvania, United States 19096.

Crixeo Clinical Trials Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Lankenau has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Stroke, Aortic Stenosis, Cryptogenic Symptomatic Transient Ischemic Attack.

Sponsors: Boston Scientific Corporation, Medtronic Cardiac Rhythm and Heart Failure, Cumberland Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lankenau?

Lankenau has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lankenau conducted?

Lankenau has 5 clinical trials on record, with 2 currently active. Their work covers Stroke, Aortic Stenosis, Cryptogenic Symptomatic Transient Ischemic Attack.

Is Lankenau accredited by Crixeo Clinical Trials?

Lankenau has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lankenau?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.